Home Biomarkers ANA-Titer

ANA-Titer

Autoimmune disorder Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: Autoimmune disorder

Overview

Antinuclear antibody (ANA) titer measures the presence and concentration of autoantibodies that bind components of the cell nucleus. It is a screening test for systemic autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren’s syndrome, systemic sclerosis, mixed connective tissue disease and some autoimmune liver disorders. The test reports a dilution titer (e.g., 1:40, 1:160) and an immunofluorescence staining pattern that can help guide further testing. Indications include unexplained chronic fatigue, arthralgia/arthritis, skin rashes (malar or photosensitive), Raynaud phenomenon, muscle weakness, recurrent fevers or cytopenias. Positivity is more common in women and increases with age; low titers can be seen in healthy people, especially older adults.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: Autoimmune disorder panel (screening test for systemic autoimmunity) - Symptoms prompting test: unexplained joint pain, rashes, photosensitivity, Raynaud’s, unexplained fevers, cytopenias, muscle weakness - Diagnoses/monitoring: screening for SLE, Sjögren’s, scleroderma, mixed connective tissue disease, autoimmune hepatitis; guides further specific antibody testing - Reasons for abnormal results: true autoimmune disease, infections, certain drugs (drug-induced lupus), aging, transient immune activation - Biological meaning: presence of autoantibodies directed against nuclear antigens suggests immune dysregulation and possible connective-tissue disease - Lifestyle/factors: some medications, recent infections, and advancing age can cause positives - Family history: relatives with autoimmune disease increases pre-test probability and lowers threshold for testing

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

A negative ANA (titer <1:40) argues against systemic autoimmune disease but does not completely exclude it.
Low-positive titers (1:40–1:80) are often nonspecific and may be seen in healthy individuals, older adults, or during infections.
Moderate titers (1:160) raise clinical suspicion for autoimmune disease and usually prompt further testing (ENA panel, anti-dsDNA, anti-Sm).
High titers (≥1:320) are strongly associated with systemic autoimmune conditions and correlate with higher likelihood of active disease.
The immunofluorescence pattern (homogeneous, speckled, nucleolar, centromere) further refines likely diagnoses.
Drug-induced lupus, chronic infections, and transient immune activation can produce positive ANAs; confirmatory and disease-specific antibodies help determine clinical significance.

Normal Range

Negative <1:40 (titer)

FAQs

Q: What does an ANA titer tell you?

A: An ANA titer measures the amount of antinuclear antibodies in blood, reported as a dilution (for example 1:40, 1:160). Higher titers and specific staining patterns raise suspicion for autoimmune diseases (like lupus, Sjögren’s, scleroderma) but are not diagnostic by themselves. Low titers may be found in healthy people; results must be interpreted alongside symptoms, exam findings and other laboratory tests.

Q: What cancers have a high ANA titer?

A: High ANA titers are not specific to autoimmune disease and can occur with malignancy, most often hematologic cancers—especially lymphomas (Hodgkin and non‑Hodgkin) and leukemias. Positive ANAs are also reported with solid tumors such as lung, breast, ovarian and liver cancers, often as part of paraneoplastic phenomena. A high ANA warrants further evaluation but is not diagnostic of cancer alone.

Q: Does positive ANA mean liver disease?

A: A positive ANA does not by itself mean you have liver disease. ANA indicates autoimmunity and can occur in healthy people or with many conditions (other autoimmune diseases, infections, drugs, aging). It may support autoimmune hepatitis when accompanied by abnormal liver tests, specific autoantibodies, symptoms and sometimes liver biopsy. Clinical evaluation and further testing are required to confirm liver involvement.

Q: What is a normal titer value?

A: A \

Q: What happens if ANA is positive?

A: A positive ANA means your immune system is making antibodies that react with cell nuclei. It can indicate autoimmune diseases (for example, lupus, Sjögren’s, scleroderma) but also appears in healthy people, older adults, infections, or with some medications. A positive result requires clinical correlation and further testing (specific autoantibodies and symptom assessment) to determine whether an autoimmune condition is present.

Q: Can ANA titer levels change over time?

A: Yes. ANA titers can change over time. They may rise with developing or active autoimmune disease, infections, certain medications, or aging, and may fall or become negative with remission, immunosuppressive treatment, or as transient post‑infectious results resolve. Because titers can fluctuate, clinicians interpret results alongside symptoms and other tests and may repeat testing when clinically indicated.